Searched for
INDIA US TARIFFS PATENTED DRUGS
India, US move closer to interim trade deal after Goyal-Greer talksIndia and the United States have made significant headway in their Bilateral Trade Agreement negotiations, with both nations expressing str...- India, US conclude two-day trade talksIndia and the United States concluded ministerial talks on a proposed trade agreement, aiming to finalize an initial deal before Washington...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- India-US trade talks gather pace as tariff clock ticksIndia and the US are pushing for an interim trade pact, with high-level talks led by Piyush Goyal and Jamieson Greer aiming for a deal befo...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Piyush Goyal, US Trade Representative Jamieson Greer begin talks on trade pactIndia and the US are in high-level talks to finalize the first phase of their bilateral trade agreement. Commerce Minister Piyush Goyal met...
- Meet with Jamieson Greer today; Piyush Goyal says India seeking export edge in US trade dealGoyal said he would be "happy" if a deal is finalised before July 24, when Washington's temporary 10% tariff on trading partners is due to ...
- India seeks tariff advantage over peers in push to finalise US trade dealIndia's trade minister, Piyush Goyal, revealed on Monday that a trade agreement with the United States is experiencing delays. The primary ...
- US strike on vessel in Caribbean Sea kills 2, leaves 6 survivorsThe U.S. military conducted another strike on a suspected drug boat in the eastern Pacific, resulting in two deaths and six survivors. This...
- US Trade Representative Jamieson Greer on visit to India to discuss trade dealU.S. Trade Representative Jamieson Greer has arrived in New Delhi to finalise an interim trade agreement with India. This visit is the culm...
- Exports up 15% despite global headwinds: Commerce and industry minister Piyush GoyalIndia's merchandise exports saw a robust 15% year-on-year growth in April-June, defying global economic headwinds, according to Commerce Mi...
- India, US to hold ministerial-level talks on bilateral trade pact this weekIn a significant development, India and the US are set to conclude the first phase of their trade agreement this week. Commerce Minister Pi...
- US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Raghuram Rajan's warning to India after Hormuz shock: Build bigger oil reserves, diversify fasterGlobal economic shocks from trade disruptions and geopolitical tensions are reshaping resilience, according to Raghuram Rajan. He stresses ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
Load More
